Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) jumped by 0.7% year on year. In 2019, the country was ranked number 9 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) at €223.5 Per Capita. Netherlands is overtaken by Finland, which was number 8 with €266.78 Per Capita and is followed by Slovakia with €197.34 Per Capita. Switzerland ranked the highest with €665.57 Per Capita in 2019, a growth of 3.2% versus 2018. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal witnessed the worst performance at -12.9% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 223.50 |
| 2018 | 224.94 |
| 2017 | 223.22 |
| 2016 | 222.96 |
| 2015 | 219.94 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
| # | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data | |
| 2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data | |
| 8 |
#8
Finland
|
266.78 | 2019 | +0.8 % | +2.2 % | View data | |
| 9 |
#9
Netherlands
|
223.50 | 2019 | -0.6 % | +0.7 % | View data | |
| 10 |
#10
Slovakia
|
197.34 | 2019 | +1.4 % | +1.0 % | View data | |